Loading organizations...
§ Venture Capital · Shanghai, China
Lihehongxin Venture Capital Partnership operates as an investment vehicle that strategically deploys capital into promising early-stage companies. The partnership primarily focuses on the life sciences and biotechnology sectors, aiming to support the development of innovative solutions and advanced technologies. Its core activity involves identifying high-potential ventures and providing the necessary resources to accelerate their growth and market presence.
Based in Shanghai, China, the partnership emerged to engage with the dynamic venture landscape, particularly within specialized scientific and technological domains. While specific founding details are not publicly emphasized, its establishment reflects a clear strategic intent to identify and cultivate enterprises poised for significant development. This measured approach underpins its investment philosophy.
Lihehongxin Venture Capital Partnership primarily serves innovative startups and emerging companies seeking crucial early-stage funding and strategic guidance. By actively collaborating with its portfolio companies, the partnership endeavors to foster their expansion and enhance their market penetration. Its long-term vision is to contribute meaningfully to the advancement of high-growth industries by backing foundational ventures at pivotal stages of their evolution.
Lihehongxin Venture Capital Partnership has 1 tracked investment across 1 company. The latest tracked deal is $31.4M Series B in QureBio in December 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 24, 2021 | QureBio | $31.4M Series B | — | Longmen Capital, Oriza Holdings |